Pharmagreen Biotech Inc Quick Ratio (PHBI) starting from the third quarter 2023 to third quarter 2022, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket
 


Pharmagreen Biotech Inc   (PHBI)

Pharmagreen Biotech Inc 's Quick Ratio

PHBI's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the third quarter 2023, Quick Ratio fell to 0 a new company low.

Within Special Transportation Services industry 17 other companies have achieved higher Quick Ratio than Pharmagreen Biotech Inc in third quarter 2023. While Quick Ratio total ranking in the third quarter 2023 has deteriorated compared to the prior quarter from 4298 to 6063.

Explain Quick Ratio?
How much Cash & cash equivalents PHBI´s has?
What are PHBI´s Current Liabilities?




PHBI Quick Ratio (Jun 30 2023)
Q3
(Mar 31 2023)
Q2
(Dec 31 2022)
Q1
(Sep 30 2022)
Q4
(Jun 30 2022)
Q3
Y / Y Current Liabilities Change 9.09 % -19.42 % 0.94 % -5.64 % 9.27 %
Y / Y Cash & cash equivalent Change -78.09 % 142.56 % 138.34 % -68.32 % 26.25 %
Quick Ratio MRQ 0 0 0.01 0 0.01
PHBI's Total Ranking # 6063 # 4298 # 2461 # 5245 # 3731
Seq. Current Liabilities Change 5.4 % 7.38 % 0.35 % -3.95 % -22.15 %
Seq. Cash & cash equivalent Change -28.04 % -70.41 % 211.43 % -66.96 % 696.78 %



Quick Ratio third quarter 2023 Company Ranking
Within: No.
Special Transportation Services Industry # 18
Transportation Sector # 121
Overall Market # 6063


Quick Ratio Statistics
High Average Low
0.01 0.01 0
(Dec 31 2022)   (Mar 31 2022)




Financial Statements
Pharmagreen Biotech Inc 's Current Liabilities $ 2 Millions Visit PHBI's Balance sheet
Pharmagreen Biotech Inc 's Cash & cash equivalent $ 0 Millions Visit PHBI's Balance sheet
Source of PHBI's Sales Visit PHBI's Sales by Geography


Cumulative Pharmagreen Biotech Inc 's Quick Ratio

PHBI's Quick Ratio for the trailling 12 Months

PHBI Quick Ratio

(Jun 30 2023)
12 Months
(Mar 31 2023)
12 Months
(Dec 31 2022)
12 Months
(Sep 30 2022)
12 Months
(Jun 30 2022)
12 Months
Y / Y Current Liabilities TTM Growth -4.86 % -5.11 % 10.29 % -11.65 % -15.05 %
Y / Y Cash & cash equivalent TTM Growth -27.58 % 11.36 % -12 % -34.79 % -20.68 %
Quick Ratio TTM 0.01 0.01 0.01 0.01 0.01
Total Ranking TTM # 4703 # 5535 # 5611 # 5949 # 4830
Seq. Current Liabilities TTM Growth 2.3 % -5.93 % 0.21 % -1.35 % 2.03 %
Seq. Cash & cash equivalent TTM Growth -29.32 % 7.2 % 31.64 % -27.4 % 8.69 %


On the trailing twelve months basis In Spite of the rise in Current Liabilities in the Q3 2023 to $2.17 millions, cumulative Quick Ratio remained unchanged at 0.01 below the Pharmagreen Biotech Inc average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Special Transportation Services industry 10 other companies have achieved higher Quick Ratio than Pharmagreen Biotech Inc . While Quick Ratio overall ranking has improved so far to 4744, from total ranking during the twelve months ending second quarter 2023 at 4752.

Explain Quick Ratio?
How much Cash & cash equivalents PHBI´s has?
What are PHBI´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Special Transportation Services Industry # 11
Transportation Sector # 67
Within the Market # 6063


trailing twelve months Quick Ratio Statistics
High Average Low
0.02 0.01 0.01
(Jun 30 2020)   (Sep 30 2022)




Companies with similar Quick Ratio in the quarter ending Jun 30 2023, within Special Transportation Services Industry Quick RatioJun 30 2023 MRQ Cash & cash equivalentJun 30 2023 MRQ Current Liabilities
Pharmagreen Biotech Inc 0.00 $ 0.005  Millions$ 2.172  Millions

Date modified: 2026-09-12T06:24:39+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.